Volume 18, Issue 1 (Jan-Feb 2024)                   mljgoums 2024, 18(1): 27-28 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kumar U, Mutalik A, Shanmugam J, Kumar M. Hepatitis and community: The current scenario and a roadmap for 2030. mljgoums 2024; 18 (1) :27-28
URL: http://mlj.goums.ac.ir/article-1-1586-en.html
1- KMCH Institute of Health Sciences and Research, Coimbatore, India
2- KMCH Institute of Health Sciences and Research, Coimbatore, India , kumar.mohan324@gmail.com
Abstract:   (364 Views)
Background: Viral hepatitis is increasingly being recognized as a public health problem, requiring special attention. The World Health Organization (WHO) estimated that in 2019, 296 million people globally (3.8%) had chronic hepatitis B virus (HBV) infection, and 58 million people (0.8%) were living with hepatitis C virus (HCV). To add to this, every year, about 1.5 million people are newly infected with either hepatitis B or C viruses. The Global Health Sector Strategy (GHSS) has aimed to eliminate viral hepatitis as a major public health problem by 2030.
Methods: We conducted a desk review to identify strategies for preventing viral hepatitis and develop a roadmap to attain the sustainable development goals (SDG) target by 2030 (particularly in low- and middle-income countries). A search was done in PubMed via Medline on 1 December 2022.
Results: The focus has to be on key interventions, including hepatitis B vaccination (part of the routine child immunization along with rescheduling the birth dose to up to 7 days post-term, adult vaccination, for targeted groups like health care providers, rag pickers, waste handlers, and sanitation workers), ensuring safe injection practices and blood transfusion, harm reduction interventions for people who inject drugs (PWID), adequate testing for early diagnosis, and ensuring appropriate treatment.
Conclusion: It is the need of the hour to prioritize key interventions identified in the review for preventing viral hepatitis.
Full-Text [PDF 282 kb]   (115 Downloads) |   |   Full-Text (HTML)  (29 Views)  
Research Article: Review Article | Subject: Virology
Received: 2022/10/22 | Accepted: 2024/01/24 | Published: 2024/06/19 | ePublished: 2024/06/19

1. World Health Organization. Interim guidance for country validation of viral hepatitis elimination. 2021. [View at Publisher] [Google Scholar]
2. Nelson NP, Easterbrook PJ, McMahon BJ. Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. Clin Liver Dis. 2016; 20(4): 607-628. [View at Publisher] [DOI] [PMID] [Google Scholar]
3. World Health Organization. Final global health sector strategies on respectively, HIV, viral hepatitis and sexually transmitted infections, 2022-2030. [View at Publisher] [Google Scholar]
4. Parija PP, M MK. Hepatitis B vaccine birth dose in India: time to reconsider. Hum Vaccin Immunother. 2020; 16(1): 158-160. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Lahariya C, Subramanya BP, Sosler S. An assessment of hepatitis B vaccine introduction in India: Lessons for roll out and scale up of new vaccines in immunization programs. Indian J Public Health. 2013; 57(1): 8-14. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. National Health Mission. National Viral Hepatitis Control Program (NVHCP). India:Himachal Pradesh;2018. [View at Publisher]
7. Rehan HS, Chopra D, Sah RK, Chawla T, Agarwal A, Sharma GK. Injection practices of healthcare professionals in a Tertiary Care Hospital. Journal of Infection and Public Health. 2012; 5(2): 177-181. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. World Health Organization. People who inject drugs.2021. [View at Publisher]
9. Lange B, Cohn J, Roberts T, Camp J, Chauffour J, Gummadi N, et al. Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses. BMC Infect Dis. 2017; 17(Suppl 1): 700. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Gupta V; Kumar A; Sharma P; Arora A. Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India. Indian Journal of Medical Research. 2017; 146(1): 23-33. [View at Publisher] [DOI] [PMID] [Google Scholar]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.